Analysts Offer Insights on Healthcare Companies: Brookdale Senior Living (BKD) and Coya Therapeutics, Inc. (COYA)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Brookdale Senior Living (BKD – Research Report) and Coya Therapeutics, Inc. (COYA – Research Report) with bullish sentiments.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Brookdale Senior Living (BKD)
Bank of America Securities analyst Joanna Gajuk maintained a Buy rating on Brookdale Senior Living today. The company’s shares closed last Thursday at $15.41.
According to TipRanks.com, Gajuk is a 3-star analyst with an average return of
Currently, the analyst consensus on Brookdale Senior Living is a Strong Buy with an average price target of $16.50, which is a -0.4% downside from current levels. In a report released today, Barclays also maintained a Buy rating on the stock with a $18.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Coya Therapeutics, Inc. (COYA)
In a report released today, Chad Messer from Lake Street maintained a Buy rating on Coya Therapeutics, Inc., with a price target of $17.00. The company’s shares closed last Wednesday at $4.85, close to its 52-week low of $4.75.
According to TipRanks.com, Messer is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Coya Therapeutics, Inc. with a $17.00 average price target.
